Avicanna Inc
Healthcare · EUR · F
Price
€0.08
Cap
€18.24M
Earnings
—
30d Trend
-5.9%
58% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 39×Macro 0.99 (−1%)=39
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder — quality business with growth runway
BRAIN47'S ASSESSMENT
I rate Avicanna Inc at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 61/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-13.3%
3 MONTHS
-27.8%
12 MONTHS
-50.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder — quality business with growth runway. Quality (61) and Fundamentals (50) are the primary strengths. I note that momentum is the weakest area at 11/100 — this warrants monitoring. Historical volatility is elevated at 58%. I classify this as a speculative position — elevated volatility at 58% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.